MICHAEL FOSTER: Open Payments
NPI 1033824941 · BROOKHAVEN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,602 in 65 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,452 · 2025 $1,602
Food & beverage: $1,602
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 16 | $489 |
| ViiV Healthcare Company | 12 | $321 |
| Napo Pharmaceuticals Inc | 3 | $105 |
| Merck Sharp & Dohme LLC | 5 | $104 |
| Axsome Therapeutics, Inc. | 4 | $94 |
| AstraZeneca Pharmaceuticals LP | 4 | $82 |
| Novo Nordisk Inc | 3 | $65 |
| ABBVIE INC. | 3 | $60 |
| Azurity Pharmaceuticals, Inc. | 3 | $57 |
| Exact Sciences Corporation | 3 | $57 |
Products named: CABENUVA, Mytesi, PIFELTRO, Auvelity, AIRSUPRA, AZMIRO, DOVATO, Tlando.
Industry payments across GA — which companies pay providers there.
